Editor’s Take Video

Bioclinica Acquires MDDX Research & Informatics Combining Advanced Image Management Cloud Technology with Its Scientific and Medical Imaging Leadership

November 7, 2017

Best-in-class solution ensures sponsors and CROs have global access to efficient, accurate, and scalable medical imaging to drive better data and outcomes DOYLESTOWN, Pa., Nov. 6, 2017 – Bioclinica®, the world-leading provider of scientific-enabled Medical Imaging, eHealth, and patient-centric solutions supporting clinical research, today announces it has acquired Silicon Valley-based MDDX Research & Informatics, adding […]

DIA 2017 Editor’s Take – Cognizant

August 1, 2017

Bhaskar Sambasivan discusses how executives can leverage digital technologies, key areas of focus for Life Sciences companies, managing numerous aspects in the move towards patient-centricity, and how platforms can unlock new revenue streams and provide cost savings.

DIA 2017 Editor’s Take – ERT

August 1, 2017

Jim Corrigan discusses the risks associated with clinical trials, clearing the hurdle of paper in clinical research, the most promising and exciting advancements in the eclinical space, where the eclinical space will be five years from now, and the new era of collaboration.

DIA 2017 Editor’s Take – Medpace

July 28, 2017

Richard Scheyer discusses the importance of patient-centricity in rare disease studies, the benefits of customized studies, connecting with key investigators, and the increased interest in rare diseases.

DIA 2017 Editor’s Take – PAREXEL

July 28, 2017

Matthew J. Neal discusses the biggest challenge that regulatory and clinical systems need to address, how technology can be used in this cause, how global health authorities are dealing with these issues, and how data is at the center of the movement towards patient-centricity.

DIA 2017 Editor’s Take – ACM Global Laboratories

July 28, 2017

Robert A. Carlson, MD discusses digital pathology as it relates to clinical trials, how patients benefit, as well as the cause and effect of the diminishing number of pathologists.

DIA 2017 Editor’s Take – Chesapeake IRB

July 28, 2017

Jeff Wendel discusses how an IRB can streamline study startups, trends in regulatory and site identification, and working with academic medical centers to insure compliance with sIRB policy.

DIA 2017 Editor’s Take – Celerion

July 26, 2017

Staci McDonald, PharmD discusses how Celerion’s business is changing with the emergence of biosimilar drugs, why biosimilar developers choose to work with Celerion, and what they have learned in the course of their biosimilar research.

DIA 2017 Editor’s Take – Lifelines

July 21, 2017

Simon J. Griffin discusses the merits of adding a Cloud-based video EEG component to a trial protocol, which therapeutic categories benefit the most from this, and how a Cloud strategy can improve recruitment and randomization goals.

DIA 2017 Editor’s Take – Cmed

July 21, 2017

David Connelly discusses Cmed’s new Encapsia product, its benefits in the clinical trials process, how sponsors can use it, and its current availability.

DIA 2017 Editor’s Take – Medidata Solutions

July 21, 2017

Andrew Cassel discusses Machine Learning technology, and the practical applications of predictive modeling and genomics in clinical trials.

DIA 2017 Editor’s Take – INC Research

July 21, 2017

Judith Ng-Cashin discusses running clinical trials for rare diseases, including critical factors, engaging patients, additional stakeholders, and the growing amount of clinical research in the rare disease space.

DIA 2017 Editor’s Take – ICON

July 21, 2017

Bill Byrom discusses Bring-your-own-device (BYOD) adoption by patients in clinical trials, industry concerns, supporting evidence in favor of BYOD adoption, and thoughts on the next frontier in clinical trials.

DIA 2017 Editor’s Take – DrugDev

July 21, 2017

Eric Delente discusses how eConsent differs from the traditional informed consent procedures, the barriers keeping some organizations from converting to digital, lessons learned regarding eConsent, and how eConsent can make monitoring easier.

DIA 2017 Editor’s Take – WIRB-Copernicus Group

July 21, 2017

Donald A. Deieso PhD discusses the changing landscape for clinical and IRB services, transformative improvements in clinical research, the recent acquisitions by WIRB-Copernicus Group, and how their alliance with Huron is improving the efficiency of clinical trials.

DIA 2017 Editor’s Take – INC Research

July 21, 2017

Alastair MacDonald and Janet Baldwin discuss why Real World Evidence (RWE) is important today, insights on late-stage research, when companies should start thinking about RWE generation, recommendations on identifying and collecting RWE, and the future of RWE.

DIA 2017 Editor’s Take – Clincierge

July 19, 2017

Scott Gray discusses why recruiting a diverse patient base in clinical trials is important, the barriers to achieving patient diversity, tips for ensuring greater diversity among patients, the ROI for such practices, and an example of one of his success stories.

DIA 2017 Editor’s Take – Cardinal Health Regulatory Sciences

July 19, 2017

Jignesh Patel discusses adaptive clinical trials, how this process relates to the FDA and the 21st Century Cures Act, its benefits and limitations, and when it should be used in clinical research.

DIA 2017 Editor’s Take – Advanced Clinical

July 19, 2017

Jason Casarella discusses trends in the CRO market, challenges sponsors face today, how the industry is reponding to these challenges, and the rate of collaboration between companies in the industry.

DIA 2017 Editor’s Take – KellyOCG

July 19, 2017

Kevin Duffy discusses talent in the Life Sciences and Healthcare space, how to keep millennials on staff, and the impact of technology on talent.

DIA 2017 Editor’s Take – INC Research

July 19, 2017

Nicholas Kenny discusses innovative trial designs, collaboration in clinical research, the impact of collaboration to INC Research, sites, and sponsors, and the evolution of immunotherapy and combination trials.

DIA 2017 Editor’s Take – Worldwide Clinical Trials

July 19, 2017

Peter Benton discusses current trends in the CRO space, how Worldwide Clinical Trials is responding to these trends, challenges sponsors currently face, what the “Cure for the Common CRO” means, how to attract the best new talent through cultural changes, and how to address differences among millennials and seasoned professionals.

DIA 2017 Editor’s Take – Axiom Real-Time Metrics

July 19, 2017

Andrew Schachter discusses how small/mid-sized life sciences organizaions select EDC vendors, the concept of “Unified” in an eClinical suite, the pain points for end-users, and Axiom’s Fusion eClinical Suite.

DIA 2016 Editor’s Take – WIRB-Copernicus Group and Certara

July 27, 2016

Donald Deieso, Ph.D., of WIRB-Copernicus Group and Edmundo Muniz, M.D., Ph.D., of Certara discuss some of the challenges facing the pharmaceutical industry today; what can be done to enhance the chances of drugs making it to market; and ways to improve patient access, accelerate innovative medicines, and improve safety in healthcare.

DIA 2016 Editor’s Take – inVentiv Health

July 27, 2016

Greg Skalicky of inVentiv Health discusses the various industry dynamics impacting clinical research, as well as why it’s important to marry the clinical and commercial sides of the business together.

DIA 2016 Editor’s Take – INC Research (Anderson)

July 27, 2016

Marty Anderson of INC Research discusses the unique challenges facing vaccine trials, and how to overcome them.

DIA 2016 Editor’s Take – DrugDev

July 27, 2016

Brett Kleger of DrugDev talks about collaboration, standardization, and bringing a beautiful technology experience into clinical research.

DIA 2016 Editor’s Take – Worldwide Clinical Trials

July 27, 2016

Peter Benton of Worldwide Clinical Trials talks about the challenges facing clinical trial sponsors, where drug and device innovations will come from, and how to attract the best and brightest talent.

DIA 2016 Editor’s Take – KellyOCG

July 27, 2016

Kevin Duffy of KellyOCG outlines talent engagement obstacles in life-science organizations and the risks companies face by not having an evolving talent strategy.

DIA 2016 Editor’s Take – ClinicalRM

July 27, 2016

Kevin Bickford and Joseph Sgherza of ClinicalRM discuss preparing for and responding to global health crises and pandemics, such as Zika and Ebola.

FEEDBACK